免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

NCT:NCT05886218 · COMPLETED

NCT IDNCT05886218
狀態COMPLETED
開始日期2024-01-08
完成時間2025-08-27
SponsorUniversity of California, Davis (OTHER)
First posted
Last updated

簡要摘要

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑